prikaz prve stranice dokumenta Suportivna terapija kod karcinoma dojke
  Download
PDF 971.62 KB
master's thesis
Suportivna terapija kod karcinoma dojke
Zagreb: University of Zagreb, Faculty of Pharmacy and Biochemistry, 2022. urn:nbn:hr:163:326881
Borić, Magdalena
University of Zagreb
Faculty of Pharmacy and Biochemistry
Centre for applied pharmacy

Institutional repository: Repository of Faculty of Pharmacy and Biochemistry University of Zagreb

Cite this document

Borić, M. (2022). Suportivna terapija kod karcinoma dojke (Master's thesis). Zagreb: University of Zagreb, Faculty of Pharmacy and Biochemistry. Retrieved from https://urn.nsk.hr/urn:nbn:hr:163:326881

Borić, Magdalena. "Suportivna terapija kod karcinoma dojke." Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, 2022. https://urn.nsk.hr/urn:nbn:hr:163:326881

Borić, Magdalena. "Suportivna terapija kod karcinoma dojke." Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, 2022. https://urn.nsk.hr/urn:nbn:hr:163:326881

Borić, M. (2022). 'Suportivna terapija kod karcinoma dojke', Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, accessed 14 May 2024, https://urn.nsk.hr/urn:nbn:hr:163:326881

Borić M. Suportivna terapija kod karcinoma dojke [Master's thesis]. Zagreb: University of Zagreb, Faculty of Pharmacy and Biochemistry; 2022 [cited 2024 May 14] Available at: https://urn.nsk.hr/urn:nbn:hr:163:326881

M. Borić, "Suportivna terapija kod karcinoma dojke", Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, 2022. Available at: https://urn.nsk.hr/urn:nbn:hr:163:326881

Metadata
TitleSuportivna terapija kod karcinoma dojke
Title (english)Supportive care in breast cancer
AuthorMagdalena Borić
MentorIva Mucalo (mentor)
Committee memberIva Mucalo (predsjednik povjerenstva)
Committee memberLidija Bach-Rojecky (član povjerenstva)
Committee memberJasna Jablan (član povjerenstva)
GranterUniversity of Zagreb
Faculty of Pharmacy and Biochemistry
(Centre for applied pharmacy)
Zagreb
Defense date and country2022-09-15, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Pharmacy
Pharmacy
Abstract
Lijekovi koji se koriste u liječenju karcinoma dojke imaju raznovrsne načine djelovanja te ne djeluju samo na tumorsko tkivo nego i na ostale dijelove tijela, rezultirajući nuspojavama. Jedne od najčešćih nuspojava uključuju mučninu, povraćanje, bol, proljev, konstipaciju, umor, gubitak kose, anemiju itd. te iste mogu smanjiti kvalitetu života, otežati ili prekinuti liječenje ili ugroziti sam život pacijenta. Srećom, većina nuspojava može se kupirati odgovarajućim nefarmakološkim mjerama, dodacima prehani i lijekovima, a tu važnu ulogu ima i ljekarnik koji svojim znanjem pravovremeno reagira i predlaže pacijentu odgovarajuću terapiju. Time se poboljšava kvaliteta života pacijenta, omogućava se nastavak liječenja i smanjuju troškovi u zdravstvu.
Abstract (english)
Medicines used in treatment have various modes of action and do not only affect tumor tissue, but also other parts of the body, resulting in side effects. One of the most common are nausea, vomiting, pain, diarrhea, constipation, fatigue, hair loss, anemia etc., which can reduce the quality of life, complicate or interrupt the treatment, and endanger the life of the patient. Fortunately, most of the side effects can be controlled with appropriate non-pharmacological measures, dietary supplements and medicines, where the pharmacist plays an important role using his knowledge to respond in a timely manner and suggesting the appropriate therapy to the patient. This improves the patient's quality of life, enables the continuation of treatment and reduces healthcare costs.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:163:326881
Study programmeTitle: Pharmacy
Study programme type: university
Study level: integrated undergraduate and graduate
Academic / professional title: magistar/magistra farmacije (magistar/magistra farmacije)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2022-09-16 08:19:48